Corrected: Silicon Labs Q2 revenue rises on segment growth; co suspends guidance on pending acquisition
CORRECTED-Silicon Labs Q2 revenue rises on segment growth; co suspends guidance on pending acquisition Corrects throughout to remove estimates on Net Loss and Operating Loss
Overview
US wireless IoT chipmaker's Q2 revenue up 18% yr/yr, slightly beating analyst expectations
GAAP net loss narrowed compared to last year
Company suspended forward guidance due to pending Texas Instruments acquisition
Outlook
Company has suspended forward-looking guidance due to pending acquisition by Texas Instruments
Result Drivers
SEGMENT GROWTH - Industrial & Commercial revenue rose 23% yr/yr and Home & Life revenue rose 12% yr/yr, per co
MEDICAL SEGMENT - Medical achieved record revenue in the quarter, up 78% yr/yr, according to co
ORDER MOMENTUM - Bookings and new orders accelerated, while inventory at both our distributors and end customers declined, per co
Company press release: ID:nPn8SFNqTa
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Slight Beat* | $228.19 mln | $227.97 mln (5 Analysts) |
Q2 Net Loss |
| $10.59 mln |
|
Q2 Operating Loss |
| $10.67 mln |
|
Q2 Gross Profit |
| $140.67 mln |
|
Q2 Operating Expenses |
| $151.34 mln |
|
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 11 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the semiconductors peer group is "buy"
Wall Street's median 12-month price target for Silicon Laboratories Inc. is $231.00, about 5.8% above its August 10 closing price of $218.43
The stock recently traded at 58 times the next 12-month earnings vs. a P/E of 68 three months ago
Reuters Recommended Reads
Aug 11 - Ambiq Micro Q2 sales beat estimates on edge AI demand
Aug 10 - Ceva Q2 revenue beats analyst estimates on AI demand
Aug 10 - GCT Semiconductor Q2 revenue falls, net loss widens
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Silicon Laboratories
See all newsSilicon Laboratories Inc. reports results for the quarter ended June 30 - Earnings Summary
Corrected: Silicon Labs Q2 revenue rises on segment growth; co suspends guidance on pending acquisition
Brief: Silicon Laboratories Q2 Revenue USD 228.189 Million Vs. IBES Estimate USD 228 Million
Silicon Laboratories Inc expected to post earnings of 68 cents a share - Earnings Preview
Nordic Semi falls as Dexcom filing raises dual-sourcing concerns